Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Potassium Citrate for Ureteral Stent Encrustation
NCT06819553Phase 3Active, not recruiting
- Sponsor
- Zagazig University
- Start
- Nov 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of potassium citrate in urolithiasis (2 arms), sponsored by Zagazig University. Primary endpoint: Rate of encrustation on the ureteral stents. Started Nov 2024; status: active, not recruiting.
02
Drugs
potassium citrate
03
Conditions
urolithiasis
Beyond the preview
Go deeper on NCT06819553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06819553.